Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |